Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer

<table>Immunohistochemical detection of NeuGc-GM3 ganglioside in neuroectodermal tumors. (a) Neuroblastoma (NMYC-amplified). (b) Ewing sarcoma family of tumors (ESFT). (c) Negative isotype control staining (mouse IgG1) in neuroblastoma. (d) No expression in nontumoral neural tissue. Original magnification 400X (a, b and c), 100X (d), 1,000X (insets).</table>

Journal of Immunology Research

fig1

Figure 1

Figure 1: Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer 

Figure 1 | Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer 